Wilsher, Margaret
Auckland City Hospital
3 papers on CoChatORCID 0000-0003-2046-8957
Most cited papers
- Verified
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials
Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., et al. (2023) · JAMA
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 148
- Verified
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial
West, A., Chaudhuri, N., Barczyk, A., Wilsher, M. L., Hopkins, P., Glaspole, I., Corte, T. J., Šterclová, M., Veale, A., Jassem, E., et al. (2023) · Thorax
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 67
- Verified
Safety and Efficacy of Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study
Wilsher, M. L., Woodhead, F. A., Nair, D., Bao, H., Lazarus, H. M., & Corte, T. J. (2024) · B48. NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisInhalation and Respiratory Drug Delivery
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free